Definition
Hemolytic jaundice is a form of pre‑hepatic jaundice that results from the accelerated destructive breakdown of erythrocytes (hemolysis), leading to an excess of unconjugated (indirect) bilirubin in the bloodstream.
Overview
In normal physiology, senescent red blood cells are phagocytosed by macrophages of the reticulo‑endothelial system, especially in the spleen and liver. Hemoglobin released from lysed erythrocytes is degraded to biliverdin and then to bilirubin, which is initially unconjugated and bound to albumin for transport to the liver. In hemolytic jaundice, the rate of red‑cell destruction surpasses the hepatic capacity to conjugate bilirubin, causing accumulation of the water‑insoluble, indirect form. Clinically, this manifests as yellow discoloration of the sclerae and skin, often without accompanying hepatomegaly or elevated hepatic enzymes. The condition is frequently associated with hemolytic anemias, such as sickle‑cell disease, hereditary spherocytosis, glucose‑6‑phosphate dehydrogenase (G6PD) deficiency, autoimmune hemolytic anemia, and certain infections (e.g., malaria).
Etymology/Origin
The term combines “hemolytic,” derived from the Greek haima (blood) and lytikos (able to loosen, dissolve), indicating the destruction of red blood cells, with “jaundice,” from the Old French jaunisse and Latin galbinus (yellow), describing the characteristic discoloration caused by bilirubin accumulation.
Characteristics
| Feature | Typical Findings in Hemolytic Jaundice |
|---|---|
| Bilirubin profile | ↑ Unconjugated (indirect) bilirubin; normal or mildly elevated conjugated bilirubin |
| Liver function tests | Generally normal transaminases (ALT, AST) and alkaline phosphatase |
| Hemolysis markers | ↑ Lactate dehydrogenase (LDH), ↓ Haptoglobin, ↑ Reticulocyte count |
| Peripheral blood smear | Presence of schistocytes, spherocytes, sickle cells, or other morphology depending on underlying disorder |
| Urine analysis | Typically negative for bilirubin; urobilinogen may be elevated |
| Clinical presentation | Painless scleral icterus, yellowing of skin, possible splenomegaly; anemia-related symptoms (fatigue, pallor) may coexist |
| Management | Treatment targets the underlying cause of hemolysis (e.g., cessation of offending drugs, transfusion for severe anemia, prophylactic penicillin in sickle‑cell disease). In neonates with severe hyperbilirubinemia, phototherapy or exchange transfusion may be employed to prevent kernicterus. |
Related Topics
- Pre‑hepatic jaundice – Jaundice arising from processes occurring before hepatic conjugation of bilirubin.
- Hemolytic anemia – Anemia caused by increased destruction of red blood cells; often the underlying condition in hemolytic jaundice.
- Unconjugated (indirect) hyperbilirubinemia – Elevated levels of bilirubin not yet processed by the liver, encompassing both physiological neonatal jaundice and pathological states like hemolysis.
- Gilbert syndrome – A benign hereditary condition with reduced UDP‑glucuronosyltransferase activity, leading to mild unconjugated hyperbilirubinemia; distinguished from hemolytic jaundice by the absence of hemolysis.
- Kernicterus – Neurotoxic injury to the basal ganglia due to excessive unconjugated bilirubin, a severe complication particularly relevant in newborns with untreated hemolytic jaundice.
Note: The information presented reflects current medical understanding as of the latest available literature and clinical guidelines.